Google DeepMind’s London AI Drug Spinout Eyes $50bn Valuation

Google DeepMind’s London AI drug spinout eyes $50bn valuation

London-based AI drug discovery firm, Isomorphic Labs, is reportedly seeking a valuation of up to $50bn (£37bn) in fresh funding talks, just five months after raising $2.1bn from investors. The Google DeepMind spinout, led by Nobel Prize-winning scientist Sir Demis Hassabis, is in early discussions to raise new capital at a valuation of at least [...]

Alphabet’s biolab in funding talks at $40B valuation

The company hopes the new investment will accelerate its push to develop new drugs.

Alphabet’s Isomorphic Labs in Funding Talks for at Least $40 Billion Value

Isomorphic Labs, an AI-powered drug discovery startup spun out of Alphabet Inc.’s Google DeepMind, is in early talks to raise new funds at a valuation of at least $40 billion, according to people familiar with the effort.

DeepMind spinout Isomorphic Labs eyes $40B valuation less than five months after $2.1B round: Report

Isomorphic Labs is reportedly in early talks to raise at a valuation of $40B or up to $50B. The round has not closed.

Isomorphic Labs Raised $2.1 Billion in Series B Funding in May

Alphabet’s AI drug-discovery company is considering new financing at a valuation of $40 billion to $50 billion, but no deal has closed.

Alphabet spinoff Isomorphic Labs reportedly raising funding at up to $50B valuation

Isomorphic Labs Ltd., an Alphabet Inc. spinoff working to accelerate drug discovery, is said to be raising a new funding round. The Bloomberg report that revealed the discussions today didn’t specify the size of the deal. The paper’s sources did, however, divulge that Isomorphic is eyeing a valuation of between $40 billion and $50 billion. […]